Investors

Webcasts

November 14, 2024 11:00 am ET

First Quarter Fiscal Year 2025 Operating Results Conference Call & Webcast

October 1, 2024

Palatin to Report Fourth Quarter and Fiscal Year End 2024 Results

May 15, 2024 11:00 am ET

Third Quarter, Fiscal Year 2024 Operating Results Conference Call & Webcast

May 8, 2024 10:00 am ET

Beyond GLPs: The Multiple Roles for Novel Melanocortin Receptor4 Agonists in Treating Obesity and Weight Loss Maintenance

February 28, 2024 8:30 am ET

Palatin Technologies PL9643 Phase 3 Clinical Study Results

February 15, 2024 11:00 am ET

Palatin Technologies Second Quarter Fiscal Year 2024 Operating Results Conference Call & Webcast

November 14, 2023 11:00 am ET

Palatin Technologies First Quarter Fiscal Year 2024 Operating Results Conference Call & Webcast

September 28, 2023 11:00 am ET

Palatin Technologies Fourth Quarter & Fiscal Year End 2023 Teleconference & Webcast

September 13, 2023 10:00 am ET

Palatin to Present at the H.C. Wainwright 25th Annual Global Investment Conference

August 9, 2023

Palatin to Participate in Canaccord Genuity’s 43rd Annual Growth Conference

May 16, 2023 11:00 am ET

Palatin Technologies Third Quarter Fiscal Year 2023 Financial Teleconference and Webcast

May 8, 2023 11:00 am ET

Palatin Technologies: Review of Phase 3 PL9643 Data for Dry Eye Disease

February 15, 2023 11:00 am ET

Second Quarter Fiscal Year 2023

Operating Results Conference Call & Webcast

November 14, 2022 11:00 am ET

First Quarter Fiscal Year 2023

Operating Results Conference Call & Webcast

September 22, 2022 11:00 am ET

Fourth Quarter & Fiscal Year End 2022

Operating Results Conference Call & Webcast

May 17, 2022 11:00 am ET

Palatin Technologies Third Quarter Fiscal Year 2022

Operating Results Conference Call & Webcast

March 7, 2022 11:00 am ET

KOL Webinar on Dry Eye Disease

February 15, 2022 11:00 am ET

Palatin Technologies Second Quarter Fiscal Year 2022

Operating Results Conference Call & Webcast

September 29, 2021 11:00 am ET

Palatin Fourth Quarter and Fiscal Year End 2021

Operating Results Conference Call & Webcast

May 21, 2021

Key Opinion Leader Webinar

Role of Melanocortin Agonists in Inflammation and the Treatment of Ocular Indications

May 17, 2021 11:00 am ET

Palatin Third Quarter Fiscal Year 2021

Operating Results Conference Call & Webcast

March 9, 2021 7:00 am ET

H.C. Wainwright Global Life Sciences Virtual Conference

Scroll to Top